NEVVI Medicare utilization intelligence

← back

FREEMAN, HAROLDMD NPI 1770515900 Clinician

Radiation Oncology · FORT WORTH, TX

Specialty Radiation Oncology — from billed Medicare claims
Trained UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 41 years since medical school (class of 1985, self-reported to CMS)
Location FORT WORTH, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 40 codes billed · 8,812 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TEXAS ONCOLOGY PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2011-04

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
77014 Ct guidance for insertion of radiation therapy fields
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
J1626 Injection, granisetron hydrochloride, 100 mcg
J9190 Injection, fluorouracil, 500 mg
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
77427 Radiation treatment management, 5 treatment sessions
77336 Continuing radiation therapy consultation per week
77300 Calculation of radiation therapy dose
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
77334 Design and construction of complex radiation treatment device
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
77263 Complex radiation therapy planning
96415 Administration of chemotherapy into vein, each additional hour
77290 Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
77301 High precision radiation therapy planning
77338 Design and construction of radiation treatment device for high precision radiation therapy
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
77417 X-ray during radiation therapy
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
77295 3d radiation therapy planning
J1200 Injection, diphenhydramine hcl, up to 50 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
77332 Design and construction of simple radiation treatment device
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96523 Irrigation of implanted venous access drug delivery device

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.